<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Steg, PG</style></author><author><style face="normal" font="default" size="100%">Iung, B</style></author><author><style face="normal" font="default" size="100%">Feldman, LJ</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D</style></author><author><style face="normal" font="default" size="100%">Deckers, J</style></author><author><style face="normal" font="default" size="100%">Fox, KAA</style></author><author><style face="normal" font="default" size="100%">Keil, U</style></author><author><style face="normal" font="default" size="100%">Maggioni, AP</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cardiovascular medicine-Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes</style></title><secondary-title><style face="normal" font="default" size="100%">Heart-London</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2002</style></year></dates><number><style face="normal" font="default" size="100%">1</style></number><publisher><style face="normal" font="default" size="100%">London: BMJ Pub. Group, 1996-</style></publisher><volume><style face="normal" font="default" size="100%">88</style></volume><pages><style face="normal" font="default" size="100%">20–23</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>